Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.157.140. Please contact the publisher to request reinstatement.
1.
Cornwall  JVDore  CJLewis  JD Leg ulcers: epidemiology and aetiology  Br J Surg. 1986;73693- 696PubMedGoogle ScholarCrossref
2.
Office of Health Economics, Chronic Venous Disease of the Leg.  London, England Office of Health Economics1992;24- 33Report 108.
3.
Falanga  V Venous ulceration  J Dermatol Surg Oncol. 1993;19764- 771PubMedGoogle ScholarCrossref
4.
Gourdin  FWSmith  JG Etiology of venous ulceration  South Med J. 1993;861142- 1146PubMedGoogle ScholarCrossref
5.
Linton  RR The communicating veins of the lower leg and the operative technique for their ligation  Ann Surg. 1938;107582- 593Google ScholarCrossref
6.
DePalma  RGGloviczki  PedBergan  JJed Linton's operation and modifications of the open technique  Atlas of Endoscopic Perforator Vein Surgery. London, England Springer-Verlag1998;107- 113Google Scholar
7.
Hauer  G Endoscopic subfascial discussion of perforating veins: preliminary report  Vasa. 1985;1459- 61PubMedGoogle Scholar
8.
Marques da Costa  RMiguel  FAnicet  CMendes  M Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers  Am J Surg. 1997;173165- 168PubMedGoogle ScholarCrossref
9.
Falanga  VMargolis  DAlvarez  O  et al. and the Human Skin Equivalent Investigators Group, Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent  Arch Dermatol. 1998;134293- 300PubMedGoogle ScholarCrossref
10.
Valencia  ICFalabella  AKirsner  RSEaglstein  WH Chronic venous insufficiency and venous leg ulceration  J Am Acad Dermatol. 2001;44401- 421PubMedGoogle ScholarCrossref
11.
Cabrera  JCabrera Jr  JGarcía-Olmedo  MA Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes  Phebology. 2000;1519- 23Google ScholarCrossref
12.
Weiss  RAGoldman  MP Advances in sclerotherapy  Dermatol Clin. 1995;13431- 445PubMedGoogle Scholar
13.
Cabrera  JCabrera Jr  J BTG International Limited inventors; assignee Injectable microfoam containing a sclerosing agent  US patent 5676962. October16 1997;Google Scholar
14.
Lees  TALambert  D Patterns of venous reflux in limbs with skin changes associated with chronic venous insufficiency  Br J Surg. 1993;80725- 728PubMedGoogle ScholarCrossref
15.
Shami  SKSarin  SCheatle  TR  et al.  Venous ulcers and the superficial venous system  J Vasc Surg. 1993;17487- 490PubMedGoogle ScholarCrossref
16.
Fletcher  ACullum  NSheldon  TA A systematic review of compression treatment for venous leg ulcers  BMJ. 1997;315576- 580PubMedGoogle ScholarCrossref
17.
Rhodes  JMGloviczki  PKalra  MNoel  AA Subfascial endoscopic perforating vein surgery Gloviczki  PedJS  Yaoed Handbook of Venous Disorders: Guidelines of the American Venous Forum. 2nd ed. London, England Arnold2001;391- 400Google Scholar
18.
Stuart  WPAdam  DJBradbury  AWRuckley  CV Subfascial endoscopic perforator surgery is associated with significantly less morbidity and shorter hospital stay than open operation (Linton's procedure)  Br J Surg. 1997;841364- 1365PubMedGoogle ScholarCrossref
19.
Pierik  EGvan Urk  HHop  WCWittens  CH Endoscopic versus open subfascial division of incompetent perforating veins in the treatment of venous leg ulcerations: a randomized trial  J Vasc Surg. 1997;261049- 1054PubMedGoogle ScholarCrossref
20.
Pierik  EGJMvan Urk  HWittens  CHA Efficacy of subfascial endoscopy in eradicating perforating veins of the lower leg and its relation with venous ulcer healing  J Vasc Surg. 1997;26255- 259PubMedGoogle ScholarCrossref
21.
Whiteley  MSSmith  JJGalland  RB Tibial nerve damage during subfascial endoscopic perforator vein surgery  Br J Surg. 1997;84512PubMedGoogle ScholarCrossref
22.
Stacey  MCBurnand  KGLayer  GTPattison  M Calf pump function in patients with healed venous ulcers is not improved by surgery to the communicating veins or by elastic stockings  Br J Surg. 1988;75436- 439PubMedGoogle ScholarCrossref
23.
Barwell  JRTaylor  MDeacon  J  et al.  Surgical correction of isolated superficial venous reflux reduces long-term recurrence rate in chronic venous leg ulcers  Eur J Vasc Endovasc Surg. 2000;20363- 368PubMedGoogle ScholarCrossref
24.
Darke  SGPenfold  C Venous ulceration and saphenous ligation  Eur J Vasc Surg. 1992;64- 9PubMedGoogle ScholarCrossref
25.
Queral  LAFrancisco  JC The role of sclerotherapy as an adjunct to Unna's boot for treating venous ulcers: a prospective study  J Vasc Surg. 1990;11572- 575PubMedGoogle ScholarCrossref
26.
Takeda  YAgui  TTanaka  KOkuzawa  MTanigawa  N Sclerotherapy with a ligation of incompetent veins for a stasis ulcer due to varix cruris: minimal invasive therapy for varix cruris  Surg Today. 1999;291154- 1157PubMedGoogle ScholarCrossref
27.
Cabrera  JCabrera Jr  JGarcia-Olmedo  MA Sclerosants in microfoam: a new approach in angiology  Int Angiol. 2001;20322- 329PubMedGoogle Scholar
28.
Cabrera  JCabrera Jr  JGarcia-Olmedo  MARedondo  P Treatment of venous malformations with sclerosant in microfoam form  Arch Dermatol. 2003;1391409- 1416PubMedGoogle ScholarCrossref
29.
Paul  REDurant  TMOppenheimer  MJStauffer  HM Intravenous carbon dioxide for intracardiac gas contrast in the roentgen diagnosis of pericardial effusion and thickening  Am J Roentgenol Radium Ther Nucl Med. 1957;78224- 225PubMedGoogle Scholar
30.
Meltzer  RSSerruys  PWHugenholtz  PGRoelandt  J Intravenous carbon dioxide as an echocardiographic contrast agent  J Clin Ultrasound. 1981;9127- 131PubMedGoogle ScholarCrossref
31.
Bikerman  JJ Foams.  New York, NY Springer-Verlag1973;
Study
June 2004

Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers

Author Affiliations

From the Vascular Surgery Clinic, Granada, Spain (Drs J. Cabrera, Becerra, and Garrido, Ms García-Olmedo, and Mr J. Cabrera Jr); and Departments of Dermatology, University Clinic (Drs Redondo, Sierra, and Lloret), and Epidemiology and Public Health (Dr Martínez-González), Medical School, University of Navarra, Pamplona, Spain. Dr J. Cabrera and Mr J. Cabrera, Jr have a financial interest in the commercial development of the patented microfoam. The microfoam presented in the study was made the subject of a patent application by the authors in 1993, and they have subsequently assigned the patents to BTG International Limited. Provensis Ltd, a subsidiary of BTG, has developed the patented microfoam concept into a pharmaceutical product, Varisolve, which is currently used in clinical trials in Europe and the United States.

Arch Dermatol. 2004;140(6):667-673. doi:10.1001/archderm.140.6.667
Abstract

Background  Venous leg ulceration is a frequent and severe complication of lower limb venous insufficiency. Compression therapy is associated with a protracted course of healing and multiple recurrences. Minimally invasive surgery (subfascial endoscopic perforating surgery) is only possible in a subset of patients with leg ulcers. Low-cost and noninvasive therapeutic procedures are needed as alternative treatments.

Objective  To evaluate the efficacy and safety of sclerosant in microfoam in treating venous leg ulceration.

Design  A retrospective study of medical records, pretreatment and posttreatment color photographs, and echo Doppler in patients with venous leg ulceration. All patients were evaluated at 6 months after therapy, 70% were also evaluated at 2 years, 25% at 3 years, and 14% at 4 or more years after treatment. They were assessed for complete (100%) ulcer healing, time to wound closure, and recurrence.

Setting  Private vascular surgery clinic in Granada and dermatology department at a hospital in Pamplona, Spain.

Patients  Over 115 months, 116 consecutive patients (mean age [range], 57 [25-85] years) treated with ultrasound-guided injection of polidocanol microfoam (UIPM).

Interventions  To reduce venous hypertension, UIPM was used to selectively and progressively sclerose sources of incompetence. The number of sessions per patient varied between 1 and 17 (mean, 3.6).

Main Outcome Measures  Complete ulcer healing, defined as full reepithelialization of the wound with absence of drainage. Recurrence was defined as epithelial breakdown in the healed limb.

Results  At 6-months' follow-up, treatment with UIPM achieved complete healing in 83% of patients (96/116), with median time to healing of 2.7 months; 7 patients were never cured, and 1 patient was lost to follow-up. There were recurrences in 10 patients.

Conclusions  The use of UIPM to selectively and progressively sclerose incompetent veins produced by venous hypertension is highly effective to achieve a stable ulcer healing with minimal invasion, even in elderly patients. Recurrences are easily treatable with this approach. This technique may become a first-line treatment in the management of leg venous ulcers.

×